Toray Industries announces award for groundbreaking research that uses DNA microarray analysis

NewsGuard 100/100 Score

Toray Industries, Inc. (TOKYO:3402) of Japan announces a competition award for groundbreaking research that uses DNA microarray analysis.

Toray's "3D-Gene™ Competition Award" is donated to encourage further progress and achievements of scientists using DNA microarray technology in research leading to publishing papers of superior quality about analyses using DNA microarray.

3D-Gene™ is a super-sensitive microarray. Toray has succeeded in development of a DNA microarray substrate with high sensitivity (100 times that of existing DNA microarray substrate), high reproducibility/quantification and high speed (10 times the existing substrates) based on its unique technologies such as an agitation method during hybridization using microbeads and a substrate with special configuration and gene spotting technology using nano-level control of molecules.

We seek applicants who are researchers with research plans in which gene expression analyses play an important part. Applicants of any age and affiliation are welcome. The proposed research must make full use of gene expression analysis which 3D-Gene™ could support.

The award winners will get DNA microarray analyses with 3D-Gene™ matched to each winner's research plan and a research grant of $2,000 specially for the sample preparation. The award winner will send their samples to Toray for the analysis. The whole microarray analysis will be done by Toray in Japan (basic data analysis is included).

Applications for this award will be accepted until December 10, 2009.

For details: http://www.3d-gene.com/en/demo/index.html

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baylor study reveals role of newly inherited DNA variants in recessive diseases